The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

Current Status and Future Perspective of Left Main Coronary Intervention

좌주간부 관상동맥 질환에서 경피적 중재시술의 현재와 미래 전망

  • Park, Seung-Jung (Division of Cardiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Park, Duk-Woo (Division of Cardiology, University of Ulsan College of Medicine, Asan Medical Center)
  • 박승정 (울산대학교 의과대학 서울아산병원 심장내과) ;
  • 박덕우 (울산대학교 의과대학 서울아산병원 심장내과)
  • Published : 2011.11.01
⟨ Previous Next ⟩

Abstract

For several decades, based on clinical trials comparing coronary-artery bypass grafting (CABG) with medical therapy, bypass surgery has been regarded as the treatment of choice for patients with unprotected left main coronary artery (LMCA) disease. However, because of marked advancements in techniques of percutaneous coronary intervention (PCI) with stenting and CABG and adjunctive pharmacologic therapy, new evaluation and a review of current indications for optimal revascularization therapy for LMCA disease may be required to determine the standard of care for these patients. The available current evidence suggests that the composite outcome of death, myocardial infarction and stroke is similar in patients with LMCA disease who are treated with PCI with stenting or CABG, only difference was the rate of repeat revascularization. Cumulative and emerging data from several extensive registries and a large clinical trial may have prompted many interventional cardiologists to select PCI with stenting as an alternative revascularization strategy for such patients. In addition, these data may change future guidelines and support the need for prospective, large randomized trials comparing the two revascularization treatment. Finally, these evidence will change the current clinical practice of revascularization strategy for unprotected LMCA disease.

Keywords

References

  1. Chaitman BR, Fisher LD, Bourassa MG, et al. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease: report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol 1981;48:765-777. https://doi.org/10.1016/0002-9149(81)90156-9
  2. Takaro T, Peduzzi P, Detre KM, et al. Survival in subgroups of patients with left main coronary artery disease: Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation 1982;66:14-22. https://doi.org/10.1161/01.CIR.66.1.14
  3. Park SJ, Park DW. Percutaneous coronary intervention with stent implantation versus coronary artery bypass surgery for treatment of left main coronary artery disease: is it time to change guidelines? Circ Cardiovasc Interv 2009;2:59-68. https://doi.org/10.1161/CIRCINTERVENTIONS.108.831701
  4. Park SJ, Kim YH, Lee BK, et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 2005;45:351-356. https://doi.org/10.1016/j.jacc.2004.10.039
  5. Valgimigli M, van Mieghem CA, Ong AT, et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated at Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation 2005;111:1383-1389. https://doi.org/10.1161/01.CIR.0000158486.20865.8B
  6. Chieffo A, Stankovic G, Bonizzoni E, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 2005;111:791-795. https://doi.org/10.1161/01.CIR.0000155256.88940.F8
  7. Hsueh SK, Wu CJ, Fang HY, et al. Comparison of drug-eluting stent with bare metal stent for distal de novo unprotected left main coronary artery stenosis: a propensity score-matched cohort study. Circ J 2011;75:290-298. https://doi.org/10.1253/circj.CJ-10-0468
  8. Pandya SB, Kim YH, Meyers SN, et al. Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis. JACC Cardiovasc Interv 2010;3:602-611. https://doi.org/10.1016/j.jcin.2010.03.019
  9. Chieffo A, Park SJ, Valgimigli M, et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. Circulation 2007;116:158-162. https://doi.org/10.1161/CIRCULATIONAHA.107.692178
  10. Kim YH, Park SW, Hong MK, et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol 2006; 97:1597-1601. https://doi.org/10.1016/j.amjcard.2005.12.051
  11. Valgimigli M, Malagutti P, Rodriguez Granillo GA, et al. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era: clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. Am Heart J 2006;152:896-902. https://doi.org/10.1016/j.ahj.2006.03.029
  12. Palmerini T, Sangiorgi D, Marzocchi A, et al. Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology. Eur Heart J 2009;30:2087-2094. https://doi.org/10.1093/eurheartj/ehp223
  13. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L; SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-1019. https://doi.org/10.1056/NEJMoa067722
  14. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008. https://doi.org/10.1056/NEJMoa067193
  15. Mauri L, Hsieh WH, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029. https://doi.org/10.1056/NEJMoa067731
  16. Chieffo A, Park SJ, Meliga E, et al. Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. Eur Heart J 2008;29:2108-2115. https://doi.org/10.1093/eurheartj/ehn270
  17. Meliga E, Garcia-Garcia HM, Valgimigli M, et al. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol 2008;51:2212-2219. https://doi.org/10.1016/j.jacc.2008.03.020
  18. Mehilli J, Kastrati A, Byrne RA, et al. Paclitaxel-versus sirolimuseluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2009;53:1760-1768. https://doi.org/10.1016/j.jacc.2009.01.035
  19. Seung KB, Park DW, Kim YH, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008;358:1781-1792. https://doi.org/10.1056/NEJMoa0801441
  20. Kedhi E, Joesoef KS, McFadden E, et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet 2010;375: 201-209. https://doi.org/10.1016/S0140-6736(09)62127-9
  21. Stone GW, Rizvi A, Newman W, et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med 2010;362:1663-1674. https://doi.org/10.1056/NEJMoa0910496
  22. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-224. https://doi.org/10.1056/NEJMoa0807611
  23. Jasti V, Ivan E, Yalamanchili V, Wongpraparut N, Leesar MA. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis. Circulation 2004;110:2831-2836. https://doi.org/10.1161/01.CIR.0000146338.62813.E7
  24. Courtis J, Rodés-Cabau J, Larose E, et al. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses. Am J Cardiol 2009;103:943-949. https://doi.org/10.1016/j.amjcard.2008.11.054
  25. Hamilos M, Muller O, Cuisset T, et al. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation 2009;120:1505-1512. https://doi.org/10.1161/CIRCULATIONAHA.109.850073
  26. Kang SJ, Lee JY, Ahn JM, et al. Intravascular ultrasound-derived predictors for fractional flow reserve in intermediate left main disease. JACC: Cardiovacular Interventions. 2011;In Press.
  27. Park SJ, Kim YH, Park DW, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv 2009;2:167-177. https://doi.org/10.1161/CIRCINTERVENTIONS.108.799494
  28. Kang SJ, Mintz GS, Kim WJ, et al. Effect of intravascular ultrasound findings on long-term repeat revascularization in patients undergoing drug-eluting stent implantation for severe unprotected left main bifurcation narrowing. Am J Cardiol 2011; 107:367-373. https://doi.org/10.1016/j.amjcard.2010.09.028
  29. Kang SJ, Ahn JM, Song HG, et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease. Circ Cardiovasc Interv 2011.
  30. Sheiban I, Sillano D, Biondi-Zoccai G, et al. Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). J Am Coll Cardiol 2009;54:1131-1136. https://doi.org/10.1016/j.jacc.2009.06.018
  31. Lee JY, Park DW, Kim YH, et al. Incidence, predictors, treatment, and long-term prognosis of patients with restenosis after drug-eluting stent implantation for unprotected left main coronary artery disease. J Am Coll Cardiol 2011;57:1349-1358. https://doi.org/10.1016/j.jacc.2010.10.041
  32. Takagi H, Umemoto T. Drug-eluting stents vs bypass surgery for unprotected left main disease. Circ J 2010;74:2244. https://doi.org/10.1253/circj.CJ-10-0521
  33. Chieffo A, Morici N, Maisano F, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 2006;113:2542-2547. https://doi.org/10.1161/CIRCULATIONAHA.105.595694
  34. Lee MS, Kapoor N, Jamal F, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006;47:864-870. https://doi.org/10.1016/j.jacc.2005.09.072
  35. Palmerini T, Marzocchi A, Marrozzini C, et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol 2006;98:54-59. https://doi.org/10.1016/j.amjcard.2006.01.070
  36. Sanmartin M, Baz JA, Claro R, et al. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. Am J Cardiol 2007;100:970-973. https://doi.org/10.1016/j.amjcard.2007.04.037
  37. Cheng CI, Lee FY, Chang JP, et al. Long-term outcomes of intervention for unprotected left main coronary artery stenosis: coronary stenting vs coronary artery bypass grafting. Circ J 2009;73:705-712. https://doi.org/10.1253/circj.CJ-08-0804
  38. Park DW, Seung KB, Kim YH, et al. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol 2010;56:117-124. https://doi.org/10.1016/j.jacc.2010.04.004
  39. Buszman PE, Kiesz SR, Bochenek A, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol 2008;51:538-545. https://doi.org/10.1016/j.jacc.2007.09.054
  40. Morice MC, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010;121:2645-2653. https://doi.org/10.1161/CIRCULATIONAHA.109.899211
  41. Serruys PW. The synergy between percutaneous coronary intervention with TAXUS and Cardiac Surgery (SYNTAX) Study: the 3-year outcomes of the SYNTAX trial in the subset of patients with left main disease. Transcatheter Cardiovascular Therapeutics 2010.
  42. Boudriot E, Thiele H, Walther T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol 2011;57:538-545. https://doi.org/10.1016/j.jacc.2010.09.038
  43. Park SJ, Kim YH, Park DW, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 2011;364:1718-1727. https://doi.org/10.1056/NEJMoa1100452
  44. Taggart DP, Kaul S, Boden WE, et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. J Am Coll Cardiol 2008;51:885-892. https://doi.org/10.1016/j.jacc.2007.09.067
  45. Takagi H, Kawai N, Umemoto T. Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: a meta-analysis of comparative studies. J Thorac Cardiovasc Surg 2009;137:e54-e57. https://doi.org/10.1016/j.jtcvs.2008.06.006
  46. Lee MS, Yang T, Dhoot J, Liao H. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention and drug-eluting stents in patients with unprotected left main coronary artery narrowings. Am J Cardiol 2010;105:1070-1075. https://doi.org/10.1016/j.amjcard.2009.12.007
  47. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2009;120:2271-2306. https://doi.org/10.1161/CIRCULATIONAHA.109.192663